EUCTR2012-002286-36-GB进行中（未招募）不适用
Taste and palatability of Orfadin suspension. An open, non-controlled 3-day study in pediatric patients with hereditary tyrosinemia type 1 treated with Orfadin.
Swedish Orphan Biovitrum AB0 个研究点目标入组 18 人开始时间: 2012年8月10日最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 18
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Patients with HT-1 currently managed on Orfadin (nitisinone) capsules.
- •Age from 1 month to less than 18 years.
- •Signed informed consent.
- •Are the trial subjects under 18? yes
- •Number of subjects for this age range: 18
- •F.1.2 Adults (18-64 years) no
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Any medical condition which in the opinion of the investigator makes the subject unsuitable for inclusion.
- •Enrollment in another concurrent clinical study, or intake of an investigational medicinal product (IMP), within one month prior to inclusion in this study.
- •Foreseeable inability to cooperate with given instructions or study procedures.
研究者
相似试验
进行中（未招募）
不适用
Taste and palatability of Orfadin suspension.Hereditary tyrosinemia type 1 (HT-1)MedDRA version: 14.1Level: LLTClassification code 10069459Term: Tyrosinaemia type ISystem Organ Class: 100000004850EUCTR2012-002286-36-DESwedish Orphan Biovitrum AB18
已完成
1 期
Taste and Palatability of Orfadin SuspensionHereditary Tyrosinemia, Type INCT01734889Swedish Orphan Biovitrum18
已完成
4 期
Evaluation of the Sensory Attributes of Olopatadine 0.6% and Azelastine 137mcg Nasal Sprays in Patients w/Allergic RhinitisAllergic RhinitisNCT00772304Alcon Research102
已完成
不适用
Palatability of an Oral Dispersible Tablet (ODT) Formulation in ChildrenHealthyNCT03581799University Hospital, Basel, Switzerland40
已完成
不适用
A study to determine the palatability of different dosage forms of oral N-Acetylcysteine and methionine among healthy volunteersPalatability of antidotes to paracetamol poisoningSLCTR/2016/001South Asian Clinical Toxicology Research Collaboration30